Lifeboat Foundation

New Delhi [India]: Knee replacement technology has undergone sea change with years passing by.

With time and progress in technology the surgeons and researchers are constantly working towards achieving perfection in each surgery. One such example is ‘Computer Navigated Knee Replacement Surgery.’

Pinless Computer Navigated Total Knee Replacement technology is used by Dr Anil Arora, the head of unit and lead consultant of department of Orthopedics at Max Super Specialty Hospital, for Knee Replacement, in North India.

Continue reading “Pin-less computer navigated total knee replacement, used by Dr Anil Arora in North India” »

Microsoft has announced to solve’ cancer within the next decade by ‘reprogramming’ diseased cells like computer virus.

Researchers were able to prevent the death of neurons that causes ALS by introducing a genetic mutation to prevent the SOD1 protein from clumping.

The growing resistance of Gonorrhea, alarmed the researchers.

Continue reading “Microsoft Will Treat Cancer Like Computer Virus, Vows To ‘Solve’ Cance Within 10 Years?” »

Awesome; how about Elephant tusks, etc.

In Brief.

California biotech company Pembient has announced its production of synthetic rhino horns, in the hopes of providing an ethical alternative to purchasing from poachers. Conservationist groups express worries over any unintended impact.

Continue reading “The Age of Biotech: Can Bioengineered Rhino Horns Bring An End to Poaching?” »

Just like checking your bag on a commercial airline, space travel comes with some pretty big weight restrictions. How big? According to estimates, reaching space costs a whopping $10,000 per pound, which means that every ounce saved has a big impact on the bottom line.

That’s where a group of Danish researchers comes in. The team is working on a synthetic biology project called CosmoCrops, which hopes to use bacteria to make it possible to 3D print everything needed for a respectable space mission, using a cutting-edge co-culturing system. And it could even make life better for those of us back on Earth in the process.

“We are trying to make space exploration cheaper, because many inventions we use in our daily life were invented because of space exploration, like Velcro and solar energy,” Joachim Larsen, one of the students working on the project, told Digital Trends. “The way we want to achieve this is to [be] able to produce everything from food to medicine and bioplastic for 3D printers out in space — making the space rocket a lot lighter.”

In a recent experiment, a Swedish scientist, Fredrik Lanner, a developmental biologist at the Karolinska Institute in Stockholm, attempted to modify the genes of a human embryos injecting a gene-editing tool known as CRISPR-Cas9 into carefully thawed five human embryos donated by couples who had gone through in vitro fertilization (IVF). One did not survive the cooling and thawing process, while another one was severely damaged while being injected. The remaining three embryos, which were two-days old when they were injected, survived in good shape, with one of them dividing immediately after being injected.

Scientists have viewed modifying a human embryo as over the line for safety and ethical concerns. The fear is that Lanner’s work could open the door to others attempting to use genetically modified embryos to make babies. One mistake could introduce a new disease in the human gene pool that can be inherited by future generations. Scientists are also concerned on the possibility of “designer babies,” where parents could choose traits they want for their babies.

Fredrik Lanner (right) of the Karolinska Institute in Stockholm and his student Alvaro Plaza Reyes examine a magnified image of an human embryo that they used to attempt to create genetically modified healthy human embryos. (Credit: Rob Stein/NPR)

Continue reading “Breaking Taboo: Swedish Scientist Modifies DNA in Human Embryos --‘Ignores Ethical Boundaries of Science’” »

A team of researchers at MIT and other institutions have developed miniature freeze-dried pellets that possess all of the molecular machinery required to convert DNA into proteins, which could form the basis for on-demand production of vaccines and drugs.

The pellets, which hold several enzymes and other molecules extracted from cells, can be stored for prolonged period of time at room temperature. When water and freeze-dried DNA are added, the pellets start to produce proteins encoded by the DNA.

It’s a modular system that can be programmed to make what you need, on the spot. You could have hundreds of different DNA pellets you can add in the field.

An Italian neuroscientist who wants to perform the world’s first human head transplant next year is claiming to have conducted radical spinal cord experiments on mice, rats, and a dog. Experts say the results are vague and incomplete, and that talk of human head transplants are grossly premature.

The Chan Zuckerberg Initiative just announced a new program informally called Chan Zuckerberg Science to invest $3 billion over the next decade to help cure, prevent, or manage all disease. The money comes from the $45 billion organization Mark Zuckerberg and his wife Priscilla Chan started last year to advance human potential and equality. The project will bring together teams of scientists and engineers “to build new tools for the scientific community” Priscilla Chan said on stage at an event in San Francisco.

You can watch the announcement here:

Part of the $3 billion will go to a $600 million investment in Biohub, a new physical location that will unite researchers from Stanford, Berkeley, and UCSF with elite engineers to find new ways to treat disease.

Continue reading “Chan Zuckerberg Initiative announces $3 billion investment to cure disease” »

Synthego, the stealthy genome engineering startup, has announced its release of the world’s first single guide RNA (sgRNA) kit for use in CRISPR/Cas9 editing. The kit is one of several CRISPR genome editing products in the company’s flagship portfolio, known as CRISPRevolution, that was debuted in August of this year.

The importance of the kits within the larger scope of CRISPR genome editing was emphasized by Synthego CEO Paul Dabrowski in his comments on the announcement. “Our kits make world-class genome engineering tools accessible to all scientists,” he said. “They accelerate research and adoption of CRISPR to help make it a standard lab technique. By drastically reducing the time to begin a CRISPR experiment with our rapid turnaround, improving gene editing quality and consistency, and bringing the cost down, we’re closing the gap between CRISPR’s full potential and what’s possible in the lab today.”